Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Pre-Tax Income : $-25.55 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Cyclacel Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cyclacel Pharmaceuticals's pretax income for the three months ended in Dec. 2023 was $-5.69 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-25.55 Mil. Cyclacel Pharmaceuticals's pretax margin was -18,364.52%.

During the past 13 years, Cyclacel Pharmaceuticals's highest Pretax Margin was -848.05%. The lowest was -6083.57%. And the median was -1633.93%.

Cyclacel Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Cyclacel Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclacel Pharmaceuticals Pre-Tax Income Chart

Cyclacel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-9.13

-9.68

-22.19

-25.92

-25.55

Cyclacel Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-9.00	-7.12	-6.03	-6.70	-5.69

Competitive Comparison of Cyclacel Pharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, Cyclacel Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclacel Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyclacel Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cyclacel Pharmaceuticals's Pre-Tax Income falls into.

Cyclacel Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cyclacel Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-25.453	+	-0.364	+	0	+	0.266	+	3.5527136788005E-15
	=	-25.55

Cyclacel Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-5.36	+	-0.356	+	0	+	0.023	+	8.8817841970013E-16
	=	-5.69

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.55 Mil.

Cyclacel Pharmaceuticals (NAS:CYCCP.PFD) Pre-Tax Income Explanation

Cyclacel Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-5.693	/	0.031
	=	-18,364.52%

During the past 13 years, Cyclacel Pharmaceuticals's highest Pretax Margin was -848.05%. The lowest was -6083.57%. And the median was -1633.93%.

Cyclacel Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclacel Pharmaceuticals (Cyclacel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (NAS:CYCCP.PFD) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

CYCC:USA UXI:Germany

Address

200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922

Website

https://www.cyclacel.com

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.